What is it about?
Metabolic syndrome is a recognized risk factor for cardiovascular disease (CVD) and type 2 diabetes. It is a constellation of clinical and metabolic risk factors that include abdominal obesity, dyslipidemia, glucose intolerance, and hypertension.
Featured Image
Why is it important?
In the present consensus document, professionals from different scientific societies involved in the management of different MetS components, reviewed the available scientific evidence focused basically on therapeutic aspects, and established recommendations on therapeutic goals that facilitate homogenization in clinical decision-making.
Read the Original
This page is a summary of: COSMIC project: consensus on the objectives of the metabolic syndrome in clinic, Diabetes Metabolic Syndrome and Obesity, October 2018, Dove Medical Press,
DOI: 10.2147/dmso.s165740.
You can read the full text:
Contributors
The following have contributed to this page
